Measurement of Lipogenic Flux by Deuterium Resolved Mass Spectrometry Via Non-invasive Breath Analysis
NCT ID: NCT05274334
Last Updated: 2022-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5 participants
INTERVENTIONAL
2022-05-11
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Novel Approach to Assess Metabolic Flexibility in a Respiratory Chamber
NCT03839641
Bioimpedance Spectroscopy in Humans During Acute Fluid Volume Expansion With Different Crystalloid Solutions
NCT01930578
Brown Adipose Tissue as Nutrient Buffer Through Diet Induced Thermogenesis
NCT06078345
Alcohol Induced de Novo Lipogenesis in Women
NCT04829110
De Novo Lipogenesis and Insulin Sensitivity in Obese
NCT04260542
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention group
Assessment of de novo lipogenesis non-invasively in exhaled breath in overnight-fasted humans by triggering feeding response by deuterium resolved mass spectrometry.
Assessment of de novo lipogenesis non-invasively in exhaled breath
1. Healthy participants have a good nights sleep whereas they don't eat during the night and until measurements.
2. They come to the lab and make first baseline exhalation sets. An exhalation set consists of 6 exhalations in Mass Spectrometer positive mode and the same in negative mode. One exhalation set takes around 7minutes from start to finish.
3. Participants consume a single oral dose of dose of 70% 2H2O at 2 g/kg body-water.
4. Participants execute several exhalation sets over time.
5. Participants consume 300g of 'Excellence Joghurt Nature gezuckert.
6. Participants execute several exhalation sets over time.
7. After around 4.5hours with regular exhalation sets taking place, the trial is concluded.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment of de novo lipogenesis non-invasively in exhaled breath
1. Healthy participants have a good nights sleep whereas they don't eat during the night and until measurements.
2. They come to the lab and make first baseline exhalation sets. An exhalation set consists of 6 exhalations in Mass Spectrometer positive mode and the same in negative mode. One exhalation set takes around 7minutes from start to finish.
3. Participants consume a single oral dose of dose of 70% 2H2O at 2 g/kg body-water.
4. Participants execute several exhalation sets over time.
5. Participants consume 300g of 'Excellence Joghurt Nature gezuckert.
6. Participants execute several exhalation sets over time.
7. After around 4.5hours with regular exhalation sets taking place, the trial is concluded.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaking, or good knowledge of the English language
* Able to understand the study
* Able to give informed consent
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss National Science Foundation
OTHER
Fondation Botnar
UNKNOWN
University Children's Hospital Basel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pablo Sinues, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Universitäts-Kinderspital beider Basel (UKBB)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Children's Hospital Basel (UKBB)
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-00099; ks22Sinues
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.